Calls
1
u/Quorum_Ataraxia
Reddit r/ValueInvesting
Win Rate
0.0%
return
-20.0%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 05
$54.21
-20.0%
The author argues NVO is still fundamentally a diabetes company, with diabetes care generating 76% of 2024 revenue and roughly doubling from 2020 to 2024, even as obesity grows fast. He contends the market overweights the obesity narrative and underappreciates the structural growth and scale of the diabetes franchise. He also highlights persistently high returns on assets (mid-to-high teens to low-20s ROA) predating semaglutide, attributing this to operational discipline, manufacturing expertise, and capital allocation, which he sees as a compounding machine.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Quorum_Ataraxia has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: NVO.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
